Bu sayfada
ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 4, 2026
$64,19
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$34,6152 haftanın en düşüğü
$95,4952 haftanın en yükseği
Piyasa Değeri (MRQ)
$9.06B
P/E (TTM)
-29.4
Hisse Başına Kâr (TTM)
$-2.18
Gelir (TTM)
$669M
rozetleriniz
52 Haftlık Aralık
$35–$95
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$107
P/E
-29.4
ROE
-64.8%
Net Kâr Marjı
-47.8%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ARWR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$64.19
Piyasa Değeri (MRQ)
$9.06B
P/E (TTM)
-29.4
Hisse Başına Kâr (TTM)
$-2.18
Gelir (TTM)
$669M
ROE (TTM)
-64.8%
52 Haftlık Aralık
$35–$95
ARWR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 17 Kasım 2011 | 1-for-10 | Ters |
| 15 Ocak 2004 | 1-for-65 | Ters |
Arrowhead Pharmaceuticals, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar711
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$829M2016-09-30 → 2025-09-30
Hisse Başına Kâr$-0.012017-09-30 → 2025-09-30
Serbest Nakit Akışı$157M2016-09-30 → 2025-09-30
Net kar marjı-47.8%2016-09-30 → 2025-09-30
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ARWR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -29.45Y ort. ≈-706.5 | ≈-706.5 | · | · | |
| F/S (TTM) | 13.55Y ort. ≈19.8 | ≈19.8 | 26.5 | Düşük değerli | |
| F/D (MRQ) | 19.55Y ort. ≈11.3 | ≈11.3 | 8.5 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -120.65Y ort. ≈11.7 | ≈11.7 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -153.45Y ort. ≈4.9 | ≈4.9 | 63.7 | Düşük değerli | |
| Fiyat / Maddi Defter Değeri (MRQ) | 19.75Y ort. ≈12.1 | ≈12.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ARWR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -33.8%5Y ort. ≈-63.6% | ≈-63.6% | -53.6% | Zayıf | |
| FAVÖK Marjı (TTM) | -30.2%5Y ort. ≈-59.7% | ≈-59.7% | -53.6% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -37.7%5Y ort. ≈-63.1% | ≈-63.1% | -0.23% | Zayıf | |
| Net Kâr Marjı (TTM) | -47.8%5Y ort. ≈-64.9% | ≈-64.9% | -47.2% | Zayıf | |
| ROA (TTM) | -18.3%5Y ort. ≈-19.1% | ≈-19.1% | -18.4% | En üst düzey | |
| ROE (TTM) | -64.8%5Y ort. ≈-35.1% | ≈-35.1% | -0.50% | Aynı seviyede | |
| ROIC | 12.3%5Y ort. ≈-36.6% | ≈-36.6% | 12.3% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ARWR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 5.95Y ort. ≈3.6 | ≈3.6 | 5.9 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 0.05Y ort. ≈0.6 | ≈0.6 | 3.6 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ARWR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 23258.2%5Y ort. ≈4658.3% | ≈4658.3% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 50.5%5Y ort. ≈6.6% | ≈6.6% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 56.6% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ARWR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.75Y ort. ≈0.4 | ≈0.4 | 0.3 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 243.15Y ort. ≈162.8 | ≈162.8 | 5.1 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$1.2M | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
245.8%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 6, 2026 | $-1.36 | $-1.35 | -1.0% |
| 31 Mart 2026 | $-0.93 | $-1.21 | 23.2% | |
| 31 Aralık 2025 | $0.22 | $0.26 | -14.8% | |
| 30 Eylül 2025 | $-0.18 | $-0.25 | 26.7% | |
| 30 Haziran 2025 | $-1.26 | $-1.05 | -20.5% | |
| 31 Mart 2025 | $2.75 | $-0.20 | 1461.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $829M | $4M | $241M | $243M | $138M | $88M | $169M | $16M | $31M | $158.3K | $382.0K | $175.0K | |
| R&D Expense | $607M | $506M | $353M | · | · | · | · | · | · | · | $47M | $23M | |
| SG&A Expense | $124M | $99M | $93M | $124M | $81M | $52M | $27M | $19M | $17M | $24M | $8M | $6M | |
| Operating Expenses | $731M | $605M | $446M | $422M | $287M | $181M | $108M | $72M | $68M | $82M | $96M | $53M | |
| Operating Income | $98M | $-601M | $-205M | $-179M | $-149M | $-93M | $61M | $-56M | $-37M | $-82M | $-96M | $-53M | |
| Interest Expense | · | · | $18M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-op | $5M | $-2M | $2M | $765.0K | $2M | $-583.0K | · | $7.5K | $1M | $57.4K | $417.9K | $82.1K | |
| Pretax Income | $52M | $-612M | $-206M | $-173M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| Income Tax | $21M | $-3M | $3M | $4M | $2.0K | $2.0K | $174.0K | $2.4K | $2.4K | $2.4K | $2.4K | $5.3K | |
| Net Income | $-2M | $-599M | $-205M | $-176M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| EPS (Basic) | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 | $-0.84 | $0.72 | $-0.65 | $-0.47 | · | · | · | |
| EPS (Diluted) | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 | $-0.84 | $0.69 | $-0.65 | $-0.47 | · | · | · | |
| Shares (Basic) | 133,758,000 | 119,784,000 | 106,750,000 | 105,426,000 | 103,745,000 | 100,722,000 | 93,859,000 | 83,638,469 | 73,898,598 | · | · | · | |
| Shares (Diluted) | 133,758,000 | 119,784,000 | 106,750,000 | 105,426,000 | 103,745,000 | 100,722,000 | 98,608,000 | 83,638,469 | 73,898,598 | · | · | · | |
| EBITDA | $121M | · | $-194M | $-170M | $-142M | $-89M | $64M | $-56M | $-37M | $-82M | $-96M | $-52M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | $184M | $144M | $222M | $30M | $25M | $85M | $81M | $133M | |
| Short-term Investments | $693M | · | · | $0 | $127M | $85M | · | · | · | · | · | $22M | |
| Receivables | $7M | $0 | $0 | $1M | $10M | $846.0K | $661.4K | $327.4K | $67.8K | $75.0K | · | · | |
| Prepaid Expense | $11M | $10M | $9M | $7M | $4M | $4M | $3M | $1M | $867.4K | $1M | $3M | $588.6K | |
| Other Current Assets | $14M | $5M | $4M | $20M | $2M | $2M | $3M | $640.1K | $1M | $4M | $823.6K | $48.5K | |
| Current Assets | $951M | $695M | $416M | $405M | $385M | $322M | $265M | $79M | $68M | $91M | $103M | $155M | |
| PP&E (Net) | $383M | $386M | $290M | $110M | $49M | $31M | $23M | $14M | $16M | $15M | $5M | $4M | |
| PP&E (Gross) | $463M | $444M | $332M | $142M | $72M | $47M | $35M | $24M | $23M | $20M | $10M | $8M | |
| Accum. Depreciation | $80M | $58M | $42M | $32M | $23M | $16M | $12M | $10M | $7M | $5M | $5M | $4M | |
| Intangibles | $7M | $9M | $10M | $12M | $14M | $15M | $17M | $19M | $20M | $22M | $25M | $1M | |
| Other Non-current Assets | $1M | $4M | $3M | $218.0K | $272.0K | $264.0K | $144.1K | $141.9K | $141.9K | $122.3K | $45.8K | · | |
| Total Assets | $1.39B | $1.14B | $766M | $692M | $710M | $523M | $350M | $112M | $104M | $128M | $132M | $183M | |
| Accounts Payable | $18M | $11M | $36M | $3M | $9M | $7M | $8M | $3M | $4M | $12M | $5M | $3M | |
| Accrued Liabilities | $90M | $63M | $40M | $47M | $14M | $5M | $7M | $5M | $5M | $5M | $5M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | $223.8K | $208.5K | $194.3K | · | $50.0K | |
| Current Liabilities | $195M | $103M | $105M | $139M | $147M | $41M | $97M | $12M | $19M | $26M | $16M | $12M | |
| Capital Leases | $104M | $111M | $105M | $79M | $23M | $20M | · | · | · | · | $540.8K | $758.3K | |
| Other Non-current Liabilities | · | · | · | $0 | · | · | · | $200.0K | $200.0K | $200.0K | $200.0K | $255.2K | |
| Total Debt | · | · | · | · | · | · | · | $223.8K | $208.5K | $194.3K | · | $50.0K | |
| Common Stock | $231.0K | $217.0K | $200.0K | $198.0K | $197.0K | $195.0K | $187.9K | $180.9K | $167.2K | $162.1K | $151.9K | $147.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | $583M | $514M | $494M | $427M | $391M | |
| Retained Earnings | $-1.63B | $-1.63B | $-1.03B | $-821M | $-645M | $-504M | $-419M | $-487M | $-433M | $-398M | $-317M | $-225M | |
| Treasury Stock | $53M | $0 | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $6M | $5M | $-3M | $-136.0K | $-69.0K | $18.0K | $-391.6K | $-21.6K | $33.2K | $7.4K | $-136.4K | · | |
| Stockholders' Equity | $466M | $185M | $271M | $399M | $409M | $462M | $244M | $95M | $81M | $96M | $110M | $167M | |
| Liabilities + Equity | $1.39B | $1.14B | $766M | $692M | $710M | $523M | $350M | $112M | $104M | $128M | $132M | $183M | |
| Shares Outstanding | 135,702,000 | 124,376,000 | 107,312,000 | 105,960,000 | 104,327,000 | 102,376,000 | 95,506,271 | 88,505,302 | 74,785,726 | 69,746,685 | 59,544,677 | 54,656,936 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $17M | $11M | $9M | $7M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Stock-based Comp | $63M | $74M | $78M | $121M | $77M | $43M | $12M | $8M | $8M | $12M | $10M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $54.7K | |
| Other Non-cash | $96M | · | $-37M | $-90M | $229M | $-58M | $90M | · | · | · | · | $16M | |
| Operating Cash Flow | $180M | $-463M | $-154M | $-136M | $171M | $-96M | $173M | $-47M | $-24M | $-64M | $-66M | $-35M | |
| CapEx | $23M | $141M | $177M | $53M | $24M | $12M | $12M | $1M | $8M | $4M | $2M | $2M | |
| Investing Cash Flow | $-129M | $-420M | $-96M | $-5M | $-142M | $-241M | $-48M | $-7M | $-49M | $13M | · | · | |
| Stock Issued | $241M | $429M | $0 | $0 | $0 | $250M | $61M | $57M | $12M | $52M | · | $173M | |
| Net Stock Activity | $241M | · | · | $0 | · | $250M | $61M | $57M | $12M | $52M | · | · | |
| Financing Cash Flow | $74M | $871M | $253M | $65M | $11M | $258M | $66M | $60M | $12M | $55M | · | · | |
| Net Change in Cash | · | · | · | · | $41M | $-78M | $192M | $5M | $-61M | $4M | $-51M | $113M | |
| Taxes Paid | $814.0K | $-4M | $0 | $-2.0K | $-2.0K | $103.0K | $-302.0K | $-2.4K | · | · | · | · | |
| Free Cash Flow | $157M | · | $-331M | $-189M | $148M | $-107M | $161M | $-49M | $-32M | $-68M | $-68M | $-37M | |
| Levered FCF | · | · | $-349M | · | · | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | · | -85.2% | -73.4% | -107.8% | -105.9% | 36.2% | -346.5% | -117.8% | -51627.1% | -25124.1% | -30443.6% | |
| Net Margin | -0.20% | · | -85.3% | -72.4% | -101.8% | -96.1% | 40.3% | -337.3% | · | -51614.6% | -24068.3% | -33503.0% | |
| Pretax Margin | 6.2% | · | -85.8% | -71.0% | -101.8% | -96.1% | 40.4% | -337.3% | -109.5% | -51613.1% | -24067.7% | -33554.3% | |
| EBITDA Margin | 14.5% | · | -80.7% | -69.8% | -103.0% | -101.0% | 37.9% | -346.5% | -117.8% | -51627.1% | -25124.1% | -29674.7% | |
| ROA | -0.13% | · | -28.2% | -25.1% | -22.9% | -19.4% | 29.5% | -50.5% | · | -62.8% | -58.4% | -53.3% | |
| ROE | -0.50% | · | -61.3% | -45.7% | -33.0% | -17.7% | 40.0% | -61.5% | · | -79.4% | -66.5% | -60.4% | |
| ROIC | 12.3% | · | -76.6% | -45.8% | -36.5% | -20.2% | 24.9% | -58.3% | -45.3% | -85.4% | -87.1% | -32.0% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | · | 4.0 | 2.9 | 2.6 | 7.9 | 2.7 | 6.4 | 3.6 | 3.5 | 6.5 | 13.1 | |
| Quick Ratio | 0.0 | · | 0.0 | 0.0 | 2.2 | 5.6 | 2.3 | 2.5 | 1.3 | 3.3 | 5.1 | 13.0 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | -11.2 | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | · | 0.3 | 0.3 | 0.2 | 0.2 | 0.7 | 0.1 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 243.1 | · | 341.5 | 41.7 | 24.9 | 116.8 | 341.4 | 81.7 | 439.9 | 2.1 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.43 | · | $2.53 | $3.76 | $3.92 | $4.51 | $2.56 | $1.08 | $1.09 | $1.37 | $1.85 | $3.05 | |
| Revenue / Share | $6.20 | · | $2.26 | $2.31 | $1.33 | $0.87 | $1.71 | · | · | · | · | · | |
| Cash Flow / Share | $1.34 | · | $-1.44 | $-1.29 | $1.65 | $-0.95 | $1.75 | · | · | · | · | · | |
| Cash / Share | · | · | · | · | $1.77 | $1.40 | $2.32 | $0.34 | $0.33 | $1.22 | $1.36 | $2.42 | |
| EPS (TTM) | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 | $-0.84 | $0.69 | $-0.65 | $-0.47 | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 23258.2% | -98.5% | -1.0% | 75.9% | 57.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 50.5% | -70.5% | 39.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 56.6% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $829M | $4M | $241M | $243M | $138M | $88M | $169M | $16M | $31M | $158.3K | $382.0K | $175.0K | |
| Net Income TTM | $-2M | $-599M | $-205M | $-176M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| Market Cap | $4.68B | · | $2.88B | $3.50B | $6.51B | $4.41B | $2.69B | $1.70B | $324M | $513M | $343M | $807M | |
| Enterprise Value | · | · | · | · | · | · | · | $1.67B | $299M | $427M | · | $653M | |
| P/E | -3449.0 | -3.9 | -14.0 | -19.8 | -45.9 | -51.3 | 40.8 | -29.5 | -9.2 | · | · | · | |
| P/S | 5.6 | · | 12.0 | 14.4 | 47.1 | 50.1 | 15.9 | 105.1 | 10.3 | 3237.7 | 897.8 | 4613.0 | |
| P/B | 10.0 | · | 10.6 | 8.8 | 15.9 | 9.5 | 11.0 | 17.7 | 4.0 | 5.4 | 3.1 | 4.8 | |
| P / Tangible Book | 10.2 | 13.6 | 11.0 | 9.1 | 16.5 | 9.9 | · | · | · | · | · | · | |
| P / Cash Flow | 26.1 | · | -18.7 | -25.7 | 38.0 | -46.2 | 15.6 | -35.9 | -13.5 | -8.0 | -5.2 | -22.8 | |
| P / FCF | 29.8 | · | -8.7 | -18.5 | 44.1 | -41.1 | 16.7 | -34.9 | -10.2 | -7.5 | -5.1 | -21.7 | |
| EV / EBITDA | · | · | · | · | · | · | · | -29.8 | -8.1 | -5.2 | · | -12.6 | |
| EV / FCF | · | · | · | · | · | · | · | -34.3 | -9.4 | -6.3 | · | -17.6 | |
| EV / Revenue | · | · | · | · | · | · | · | 103.3 | 9.5 | 2699.8 | · | 3732.4 | |
| Earnings Yield | -0.03% | -25.8% | -7.1% | -5.1% | -2.2% | -1.9% | 2.5% | -3.4% | -10.8% | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75M | $74M | $264M | $256M | $28M | $543M | $2M | $0 | $0 | $0 | $4M | $16M | $16M | $146M | $63M | $32M | |
| R&D Expense | $198M | $173M | $177M | $175M | $162M | $133M | $137M | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $47M | $42M | $46M | $38M | $31M | $28M | $27M | $26M | $24M | $25M | $24M | $25M | $24M | $23M | $21M | $32M | |
| Operating Expenses | $245M | $215M | $223M | $212M | $193M | $162M | $164M | $162M | $176M | $126M | $140M | $124M | $119M | $98M | $105M | $115M | |
| Operating Income | $-170M | $-141M | $41M | $44M | $-166M | $381M | $-161M | $-162M | $-176M | $-126M | $-137M | $-108M | $-103M | $48M | $-42M | $-84M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | $5M | · | $5M | $5M | $3M | · | |
| Other Non-op | $1M | $-2M | $277.0K | $5M | $-176.0K | $438.0K | $341.0K | $-3M | $760.0K | $189.0K | $421.0K | $717.0K | $306.0K | $8.0K | $507.0K | $90.0K | |
| Pretax Income | $-179M | $-138M | $28M | $36M | $-179M | $370M | $-175M | $-173M | $-174M | $-127M | $-139M | $-109M | $-103M | $48M | $-42M | $-82M | |
| Income Tax | $11.0K | $7.0K | $29.0K | $20M | $-437.0K | $2M | $103.0K | $546.0K | $0 | $0 | $-3M | $2M | $742.0K | $0 | $17.0K | $4M | |
| Net Income | $-194M | $-133M | $31M | $-24M | $-175M | $370M | $-173M | $-171M | $-171M | $-125M | $-133M | $-110M | $-103M | $49M | $-41M | $-86M | |
| EPS (Basic) | $-1.36 | $-0.93 | $0.22 | $-0.14 | $-1.26 | $2.78 | $-1.39 | $-1.36 | $-1.38 | $-1.02 | $-1.24 | $-1.03 | $-0.96 | $0.46 | $-0.39 | $-0.81 | |
| EPS (Diluted) | $-1.36 | $-0.93 | $0.22 | $-0.11 | $-1.26 | $2.75 | $-1.39 | $-1.36 | $-1.38 | $-1.02 | $-1.24 | $-1.02 | $-0.96 | $0.45 | $-0.39 | $-0.80 | |
| Shares (Basic) | 143,378,000 | 142,417,000 | 137,039,000 | · | 139,039,000 | 133,363,000 | 124,848,000 | · | 124,199,000 | 123,285,000 | 107,415,000 | · | 107,004,000 | 106,757,000 | 106,039,000 | · | |
| Shares (Diluted) | 143,378,000 | 142,417,000 | 140,706,000 | · | 139,039,000 | 134,484,000 | 124,848,000 | · | 124,199,000 | 123,285,000 | 107,415,000 | · | 107,004,000 | 108,143,000 | 106,039,000 | · | |
| EBITDA | $-164M | $-135M | $47M | · | $-160M | $387M | $-157M | · | $-172M | $-122M | $-133M | · | $-100M | $50M | $-40M | · |
Bilanço
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | $69M | $128M | $58M | · | $105M | $135M | $202M | · | |
| Short-term Investments | · | $1.60B | $715M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | $9M | $16M | $219M | $7M | $10M | $2M | $2M | $0 | · | · | · | · | $1M | $69M | $40M | · | |
| Prepaid Expense | $25M | $22M | $16M | $11M | $24M | $24M | $9M | $10M | $9M | $11M | $11M | · | $10M | $10M | $8M | · | |
| Other Current Assets | $36M | $18M | $23M | $14M | $13M | $12M | $6M | $5M | $4M | $8M | $7M | · | $7M | $14M | $25M | · | |
| Current Assets | $1.67B | $1.84B | $1.17B | $951M | $947M | $1.14B | $571M | $695M | $450M | $542M | $238M | · | $470M | $575M | $575M | · | |
| PP&E (Net) | $373M | $375M | $379M | $383M | $381M | $385M | $387M | $386M | $376M | $359M | $333M | · | $231M | $185M | $147M | · | |
| PP&E (Gross) | $471M | $466M | $465M | $463M | $455M | $453M | $450M | $444M | $430M | $409M | $379M | · | $270M | $221M | $181M | · | |
| Accum. Depreciation | $97M | $91M | $86M | $80M | $74M | $68M | $63M | $58M | $54M | $50M | $46M | · | $39M | $36M | $34M | · | |
| Intangibles | $6M | $6M | $6M | $7M | $7M | $8M | $8M | $9M | $9M | $9M | $10M | · | $11M | $11M | $12M | · | |
| Other Non-current Assets | $6M | $5M | $1M | $1M | $1M | $1M | $3M | $4M | $4M | $210.0K | $232.0K | · | $210.0K | $210.0K | $210.0K | · | |
| Total Assets | $2.11B | $2.27B | $1.60B | $1.39B | $1.38B | $1.57B | $1.01B | $1.14B | $884M | $955M | $626M | · | $796M | $891M | $891M | · | |
| Accounts Payable | $28M | $31M | $33M | $18M | $33M | $10M | $14M | $11M | $27M | $9M | $4M | · | $8M | $10M | $796.0K | · | |
| Accrued Liabilities | $86M | $77M | $130M | $90M | $65M | $78M | $59M | $63M | $48M | $37M | $47M | · | $38M | $40M | $48M | · | |
| Current Liabilities | $283M | $295M | $347M | $195M | $195M | $221M | $94M | $103M | $97M | $65M | $64M | · | $70M | $87M | $122M | · | |
| Capital Leases | $114M | $100M | $102M | $104M | $106M | $108M | $109M | $111M | $112M | $114M | $115M | · | $80M | $80M | $79M | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $669.0K | · | · | · | |
| Common Stock | $237.0K | $236.0K | $233.0K | $231.0K | $230.0K | $230.0K | $218.0K | $217.0K | $217.0K | $217.0K | $200.0K | · | $199.0K | $199.0K | $199.0K | · | |
| Retained Earnings | $-1.92B | $-1.73B | $-1.60B | $-1.63B | $-1.60B | $-1.43B | $-1.80B | $-1.63B | $-1.45B | $-1.28B | $-1.16B | · | $-916M | $-813M | $-862M | · | |
| Treasury Stock | $53M | $53M | $53M | $53M | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| AOCI | $-1M | $742.0K | $7M | $6M | $5M | $4M | $4M | $5M | $-987.0K | $-1M | $-1M | · | $-411.0K | $-332.0K | $-258.0K | · | |
| Stockholders' Equity | $466M | $614M | $568M | $466M | $522M | $683M | $53M | $185M | $331M | $484M | $160M | · | $365M | $447M | $377M | · | |
| Liabilities + Equity | $2.11B | $2.27B | $1.60B | $1.39B | $1.38B | $1.57B | $1.01B | $1.14B | $884M | $955M | $626M | · | $796M | $891M | $891M | · | |
| Shares Outstanding | 141,135,000 | 140,571,000 | 137,391,000 | 135,702,000 | 138,144,000 | 138,062,000 | 125,572,000 | 124,376,000 | 124,227,000 | 124,133,000 | 107,500,000 | 107,312,000 | 107,102,000 | 106,869,000 | 106,140,000 | · |
Nakit Akışı
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Stock-based Comp | $15M | $17M | $19M | $19M | $13M | $16M | $15M | $19M | $17M | $18M | $20M | $18M | $20M | $21M | $19M | $29M | |
| Amort. of Intangibles | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | |
| Other Non-cash | · | · | $-43M | · | · | · | $7M | · | · | · | $-8M | · | · | · | $-56M | · | |
| Operating Cash Flow | $-177M | $84M | $13M | $20M | $-155M | $460M | $-146M | $-137M | $-115M | $-92M | $-118M | $-26M | $-21M | $-32M | $-76M | $-69M | |
| CapEx | $4M | $3M | $2M | $7M | $2M | $5M | $8M | $24M | $14M | $34M | $69M | $64M | $47M | $27M | $39M | $33M | |
| Investing Cash Flow | $44M | $-894M | $-24M | $73M | $141M | $-420M | $77M | $-223M | $7M | $-269M | $65M | $31M | $-10M | $-36M | $-81M | $36M | |
| Stock Issued | · | · | $47M | $0 | $0 | $241M | $0 | $0 | $0 | · | · | $0 | $0 | · | · | · | |
| Net Stock Activity | · | · | $47M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-449.0K | $796M | $-15M | $4M | $-43M | $92M | $21M | $389M | $50M | $431M | $267.0K | $821.0K | $1M | $520.0K | $251M | $855.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $-30M | $-67M | $94M | · | |
| Taxes Paid | $22.0K | $12M | $10M | $733.0K | $0 | $92.0K | $11.0K | $-7M | $6M | $4M | $-999.0K | $0 | $0 | $0 | $0 | $-2.0K | |
| Free Cash Flow | · | · | $11M | · | · | · | $-154M | · | · | · | $-186M | · | · | · | $-114M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-192M | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -191.6% | 15.5% | · | -596.2% | 70.2% | -6456.5% | · | · | · | -3845.2% | · | -649.0% | 32.9% | -67.4% | · | |
| Net Margin | -258.2% | -180.0% | 11.7% | · | -631.1% | 68.3% | -6923.4% | · | · | · | -3741.6% | · | -650.5% | 33.3% | -66.1% | · | |
| Pretax Margin | -237.7% | -186.6% | 10.7% | · | -645.0% | 68.1% | -7004.6% | · | · | · | -3905.6% | · | -653.3% | 32.6% | -66.8% | · | |
| EBITDA Margin | -217.8% | -183.6% | 17.7% | · | -575.3% | 71.3% | -6264.5% | · | · | · | -3738.2% | · | -630.7% | 34.4% | -63.7% | · | |
| ROA | -11.1% | -6.9% | 2.4% | · | -15.5% | 29.3% | -21.1% | · | -20.3% | -13.6% | -17.5% | · | -13.3% | 6.1% | -5.4% | · | |
| ROE | -39.3% | -20.5% | 9.9% | · | -41.1% | 63.5% | -162.5% | · | -49.1% | -26.9% | -49.4% | · | -25.1% | 10.8% | -11.0% | · | |
| ROIC | -36.5% | -23.0% | 7.2% | · | -31.6% | 55.5% | -307.1% | · | -53.3% | -26.1% | -83.1% | · | -28.3% | 10.8% | -11.2% | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.2 | 3.4 | · | 4.9 | 5.1 | 6.1 | · | 4.7 | 8.3 | 3.7 | · | 6.7 | 6.6 | 4.7 | · | |
| Quick Ratio | 0.0 | 5.5 | 2.7 | · | 0.0 | 0.0 | 0.0 | · | 0.7 | 2.0 | 0.9 | · | 1.5 | 2.3 | 2.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.4 | -25.4 | · | -19.9 | 9.5 | · | · |
Verimlilik
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.2 | · | 0.0 | 0.4 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.2 | 0.1 | · | |
| Receivables Turnover | 8.2 | 8.2 | 2.4 | · | 5.1 | 15.1 | 0.1 | · | · | · | · | · | 21.3 | 4.1 | 3.1 | · |
Hisse Başına
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.30 | $4.37 | $4.14 | · | $3.78 | $4.95 | $0.42 | · | $2.66 | $3.90 | $1.49 | · | $3.41 | $4.18 | $3.55 | · | |
| Revenue / Share | $0.52 | $0.52 | $1.88 | · | $0.20 | $4.04 | $0.02 | · | $0.00 | $0.00 | $0.03 | · | $0.15 | $1.35 | $0.59 | · | |
| Cash Flow / Share | · | · | $0.10 | · | · | · | $-1.17 | · | · | · | $-1.10 | · | · | · | $-0.71 | · | |
| Cash / Share | · | · | · | · | · | · | · | · | $0.56 | $1.03 | $0.54 | · | $0.98 | $1.26 | $1.91 | · | |
| EPS (TTM) | $-2.18 | $-2.08 | $1.60 | · | $-1.26 | $-1.38 | $-5.15 | · | $-4.66 | $-4.24 | $-2.77 | · | $-1.70 | $-1.42 | $-1.46 | · |
Değerleme (TTM)
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $669M | $622M | $1.09B | · | $573M | $545M | $2M | · | $20M | $35M | $182M | · | $256M | $273M | $278M | · | |
| Net Income TTM | $-320M | $-301M | $202M | · | $-148M | $-144M | $-640M | · | $-539M | $-471M | $-297M | · | $-181M | $-150M | $-155M | · | |
| Market Cap | $11.50B | $8.81B | $9.12B | · | $2.18B | $1.76B | $2.36B | · | $3.23B | $3.55B | $3.29B | · | $3.82B | $2.71B | $4.31B | · | |
| P/E | -37.4 | -30.1 | 41.5 | · | -12.5 | -9.2 | -3.7 | · | -5.6 | -6.7 | -11.0 | · | -21.0 | -17.9 | -27.8 | · | |
| P/S | 17.2 | 14.2 | 8.4 | · | 3.8 | 3.2 | 944.3 | · | 164.3 | 100.1 | 18.1 | · | 14.9 | 10.0 | 15.5 | · | |
| P/B | 24.7 | 14.4 | 16.0 | · | 4.2 | 2.6 | 44.9 | · | 9.8 | 7.3 | 20.5 | · | 10.5 | 6.1 | 11.4 | · | |
| P / Tangible Book | 25.0 | 14.5 | 16.2 | · | 4.2 | 2.6 | 53.1 | · | 10.0 | 7.5 | 21.8 | · | 10.8 | 6.2 | 11.8 | · | |
| P / Cash Flow | · | · | 676.6 | · | · | · | -16.1 | · | · | · | -27.9 | · | · | · | -57.0 | · | |
| Earnings Yield | -2.7% | -3.3% | 2.4% | · | -8.0% | -10.8% | -27.4% | · | -17.9% | -14.8% | -9.0% | · | -4.8% | -5.6% | -3.6% | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Gelir | $829M | $4M | $241M | $243M | $138M |
| Faaliyet Kâr Marjı % | 11.9% | · | -85.2% | -73.4% | -107.8% |
| Net Gelir | $-2M | $-599M | $-205M | $-176M | $-141M |
| Seyreltilmiş Hisse Başı Kâr | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 |
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Cari Oran | 4.9 | · | 4.0 | 2.9 | 2.6 |
| Cari Oran | 0.0 | · | 0.0 | 0.0 | 2.2 |
| Metrik | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $157M | · | $-331M | $-189M | $148M |
Kurumsal Sahipler (13F) 536 dosya · $10.7B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
536
Tutulan Değer
$10.7B
Yeni pozisyonlar
124
Çıkan pozisyonlar
54
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 124 (+4 önceki Ç'ye göre) | 54 (-2 önceki Ç'ye göre) | 161 (-7 önceki Ç'ye göre) | 162 (+41 önceki Ç'ye göre) | -134K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $1.208.838.379 | 14.830.553 | 11,25% | Hisse senetleri |
| VANGUARD GROUP INC | $1.015.310.304 | 15.293.121 | 9,45% | Hisse senetleri |
| Avoro Capital Advisors LLC | $925.591.288 | 11.355.555 | 8,61% | Hisse senetleri |
| FMR LLC | $655.324.429 | 8.039.804 | 6,10% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $517.698.946 | 6.351.355 | 4,82% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $498.103.779 | 6.110.953 | 4,63% | Hisse senetleri |
| STATE STREET CORP | $464.170.106 | 5.694.640 | 4,32% | Hisse senetleri |
| NORGES BANK | $317.606.649 | 3.896.536 | 2,95% | Hisse senetleri |
| Invesco Ltd. | $316.582.884 | 3.883.976 | 2,95% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $298.813.042 | 3.530.612 | 2,78% | Hisse senetleri |
| FRED ALGER MANAGEMENT, LLC | $269.139.418 | 3.301.919 | 2,50% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $162.431.742 | 1.992.783 | 1,51% | Hisse senetleri |
| Siren, L.L.C. | $139.828.449 | 1.715.476 | 1,30% | Hisse senetleri |
| Vestal Point Capital, LP | $128.378.250 | 1.575.000 | 1,19% | Hisse senetleri |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $113.221.873 | 1.389.055 | 1,05% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $110.276.346 | 1.352.918 | 1,03% | Hisse senetleri |
| Driehaus Capital Management LLC | $110.083.820 | 1.350.556 | 1,02% | Hisse senetleri |
| NORTHERN TRUST CORP | $97.230.671 | 1.192.868 | 0,90% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $96.310.585 | 1.181.608 | 0,90% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $93.737.071 | 1.150.007 | 0,87% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $92.905.915 | 1.139.810 | 0,86% | Hisse senetleri |
| Hood River Capital Management LLC | $91.352.088 | 1.120.747 | 0,85% | Hisse senetleri |
| Holocene Advisors, LP | $90.164.487 | 1.106.177 | 0,84% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $90.119.095 | 1.436.990 | 0,84% | Hisse senetleri |
| MORGAN STANLEY | $88.425.108 | 1.084.835 | 0,82% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $83.453.449 | 1.330.996 | 0,78% | Hisse senetleri |
| Fisher Asset Management, LLC | $78.061.392 | 957.691 | 0,73% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $75.309.290 | 923.927 | 0,70% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $73.093.114 | 896.738 | 0,68% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $70.718.076 | 867.600 | 0,66% | Alım opsiyonu |
| UBS Group AG | $70.222.495 | 861.520 | 0,65% | Hisse senetleri |
| Bank of New York Mellon Corp | $70.060.927 | 859.538 | 0,65% | Hisse senetleri |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $67.673.433 | 830.247 | 0,63% | Hisse senetleri |
| Western Financial Corp/CA | $66.857.681 | 820.239 | 0,62% | Hisse senetleri |
| JPMORGAN CHASE & CO | $51.770.437 | 637.399 | 0,48% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $50.990.129 | 625.569 | 0,47% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.626.665 | 596.573 | 0,45% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $47.325.440 | 580.609 | 0,44% | Hisse senetleri |
| Pictet Asset Management Holding SA | $46.708.118 | 573.419 | 0,43% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $45.534.991 | 558.643 | 0,42% | Hisse senetleri |
| 1832 Asset Management L.P. | $43.893.135 | 538.500 | 0,41% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $41.949.773 | 514.658 | 0,39% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $39.409.678 | 483.495 | 0,37% | Hisse senetleri |
| Balyasny Asset Management L.P. | $38.370.343 | 470.744 | 0,36% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $38.221.751 | 468.921 | 0,36% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $37.668.462 | 462.133 | 0,35% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $35.176.456 | 431.560 | 0,33% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $34.600.995 | 424.500 | 0,32% | Satım opsiyonu |
| Nuveen, LLC | $33.898.624 | 415.883 | 0,32% | Hisse senetleri |
| RHUMBLINE ADVISERS | $30.557.778 | 374.897 | 0,28% | Hisse senetleri |
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc., Sarepta Therapeutics Investments, Inc. ×2 başvurular | 15 Ağustos 2025 | 0,00% | Değişiklik | · | SEC |
| Silence Therapeutics Plc ×3 başvurular | 08 Aralık 2017 | · | İlk başvuru | · | SEC |
| Novartis Institutes for BioMedical Research, Inc., Novartis AG ×2 başvurular | 28 Kasım 2017 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 33 içeriden öğrenenler · 17 yöneticiler · 16 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Christopher Richard Anzalone | Chief Executive Officer | 02 Ocak 2026 S | 3.792.739 | 0 | 25 | $-24.010.562 |
| Daniel Joseph Apel | Chief Financial Officer | 22 Nisan 2026 S | 162.905 | 0 | 3 | $-934.286 |
| Kenneth Allen Myszkowski | Chief Financial Officer | 07 Ocak 2025 S | 455.433 | 0 | 0 | $0 |
| McDonnel Paul Clayton | CFO (former) | 17 Temmuz 2009 J | · | 0 | 0 | $0 |
| Joseph Theodore Kingsley III | Chief Financial Officer | 29 Mart 2007 A | 12.000 | 0 | 0 | $0 |
| Leon Ekchian | President | 14 Kasım 2005 A | · | 0 | 0 | $0 |
| Patrick O'Brien | COO | 06 Ocak 2026 A | 547.408 | 0 | 12 | $-3.123.349 |
| Bruce D Given | Chief Operating Officer | 28 Nisan 2020 M | 850.730 | 0 | 0 | $0 |
| James C Hamilton | Chief Medical Officer | 23 Nisan 2026 S | 226.958 | 0 | 9 | $-3.926.561 |
| Tracie Oliver | Chief Commercial Officer | 02 Temmuz 2024 S | 127.107 | 0 | 0 | $0 |
| Javier San Martin | Chief Medical Officer | 05 Ocak 2024 S | 198.497 | 0 | 0 | $0 |
| Curt Bradshaw | Chief Scientific Officer | 20 Kasım 2020 S | 0 | 0 | 0 | $0 |
| Zhen Li | Snr. VP, Chem and Non-Clin Dev | 14 Ocak 2019 S | 201.700 | 0 | 0 | $0 |
| Peter Brian Leone | VP, Strategic Bus. Initiatives | 19 Ekim 2018 M | 130.000 | 0 | 0 | $0 |
| David L. Lewis | Chief Scientific Officer | 01 Ocak 2016 A | 0 | 0 | 0 | $0 |
| STEWART R BRUCE | Executive Chairman | 04 Mart 2010 A | 711.500 | 0 | 0 | $0 |
| James M Phillips JR | Secretary | 31 Mart 2004 A | · | 0 | 0 | $0 |
| Michael S Perry | Yönetim kurulu üyesi | 18 Ağustos 2026 S | 111.459 | 0 | 2 | $-2.004.418 |
| Adeoye Y Olukotun | Yönetim kurulu üyesi | 18 Ağustos 2026 S | 31.600 | 0 | 4 | $-850.543 |
| Matthew Gregory Cohen | Yönetim kurulu üyesi | 15 Haziran 2026 A | 11.882 | 0 | 0 | $0 |
| Hongbo Lu | Yönetim kurulu üyesi | 12 Mayıs 2026 S | 52.012 | 0 | 1 | $-228.334 |
| Mauro Ferrari | Yönetim kurulu üyesi | 26 Aralık 2025 S | 69.053 | 0 | 2 | $-1.020.512 |
| Victoria Vakiener | Yönetim kurulu üyesi | 19 Aralık 2025 S | 35.723 | 0 | 3 | $-679.491 |
| William D. Waddill | Yönetim kurulu üyesi | 19 Aralık 2025 S | 56.563 | 0 | 3 | $-566.039 |
| Douglas S Ingram | Yönetim kurulu üyesi | 16 Aralık 2025 A | 46.215 | 0 | 0 | $0 |
| Douglas B Given | Yönetim kurulu üyesi | 17 Aralık 2024 S | 124.167 | 0 | 0 | $0 |
| Marianne De Backer | Yönetim kurulu üyesi | 10 Ocak 2023 A | 31.267 | 0 | 0 | $0 |
| Edward W Frykman | Yönetim kurulu üyesi | 01 Ocak 2018 A | 148.852 | 0 | 0 | $0 |
| Charles Mckenney | Yönetim kurulu üyesi | 04 Mart 2015 A | 42.220 | 0 | 0 | $0 |
| Leroy T Rahn | Yönetim kurulu üyesi | 04 Mart 2010 A | · | 0 | 0 | $0 |
| David M Knott | 10% sahip | 21 Mart 2007 S | 742.600 | 0 | 0 | $0 |
| Marshall Robert Ching | 10% sahip | 23 Haziran 2005 U | 28.666 | 0 | 0 | $0 |
| James Hassard | · | 22 Haziran 2021 S | 105.750 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 75 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| ADPV · Series Portfolios Trust | 4,99% | 105.093 NS | 31 Temmuz 2026 | N-PORT |
| IBRN · iShares Trust | 4,45% | 4.021 SH | 11 Eylül 2026 | Günlük |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,08% | 16.973 NS | 31 Temmuz 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 1,90% | 98.200 SH | 02 Ekim 2026 | Günlük |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,76% | 217.383 NS | 31 Temmuz 2026 | N-PORT |
| XMMO · Invesco Exchange-Traded Fund Trust | 1,64% | 1.801.188 SH | 02 Ekim 2026 | Günlük |
| BBP · ETFis Series Trust I | 1,56% | 18.212 NS | 31 Temmuz 2026 | N-PORT |
| PAMC · Pacer Funds Trust | 1,03% | 6.557 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,82% | 47.707 NS | 31 Temmuz 2026 | N-PORT |
| IBB · iShares Trust | 0,81% | 1.011.317 SH | 11 Eylül 2026 | Günlük |
| JSMD · Janus Detroit Street Trust | 0,80% | 99.071 NS | 31 Temmuz 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,66% | 45.043 NS | 31 Temmuz 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,62% | 66.366 NS | 31 Temmuz 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,61% | 10.003 SH | 02 Ekim 2026 | Günlük |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,60% | 138.986 SH | 19 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,41% | 33.395 NS | 31 Temmuz 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,39% | 15.107 NS | 31 Temmuz 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,34% | 15.508 NS | 31 Temmuz 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,31% | 50.547 NS | 31 Temmuz 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,31% | 227.611 SH | 19 Ağustos 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,30% | 1.772.235 SH | 19 Ağustos 2026 | Günlük |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,29% | 18.702 SH | 02 Ekim 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,27% | 67.223 SH | 19 Ağustos 2026 | Günlük |
| BKMC · BNY Mellon ETF Trust | 0,26% | 19.553 NS | 31 Temmuz 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,26% | 2.069 NS | 31 Temmuz 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,25% | 72.735 NS | 31 Temmuz 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,23% | 652 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,21% | 24.642 SH | 11 Eylül 2026 | Günlük |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 61.794 NS | 31 Temmuz 2026 | N-PORT |
| IWP · iShares Trust | 0,21% | 478.561 SH | 11 Eylül 2026 | Günlük |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,20% | 13.526 NS | 31 Temmuz 2026 | N-PORT |
| IYH · iShares Trust | 0,18% | 78.886 SH | 11 Eylül 2026 | Günlük |
| FTLS · First Trust Exchange-Traded Fund III | 0,17% | 49.621 NS | 31 Temmuz 2026 | N-PORT |
| SMMD · iShares Trust | 0,16% | 72.102 SH | 11 Eylül 2026 | Günlük |
| ESML · iShares Trust | 0,15% | 51.818 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,15% | 56.561 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,14% | 357.682 SH | 19 Ağustos 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,13% | 1.615.938 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,13% | 3.068.726 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,10% | 41.974 SH | 02 Ekim 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,10% | 175.306 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,09% | 24.490 NS | 31 Temmuz 2026 | N-PORT |
| WSML · iShares Trust | 0,09% | 7.591 SH | 11 Eylül 2026 | Günlük |
| IWR · iShares Trust | 0,08% | 552.714 SH | 11 Eylül 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,07% | 9.134 SH | 02 Ekim 2026 | Günlük |
| LRND · New York Life Investments ETF Trust | 0,07% | 3.180 NS | 31 Temmuz 2026 | N-PORT |
| IWS · iShares Trust | 0,04% | 74.359 SH | 11 Eylül 2026 | Günlük |
| SMDX · Tidal Trust III | 0,04% | 602 NS | 31 Temmuz 2026 | N-PORT |
| IUSG · iShares Trust | 0,03% | 123.000 SH | 11 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,03% | 153.604 NS | 31 Temmuz 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,02% | 4.240 SH | 02 Ekim 2026 | Günlük |
| IWF · iShares Trust | 0,02% | 319.335 SH | 11 Eylül 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 22.223 SH | 19 Ağustos 2026 | Günlük |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 133.946 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 11.327 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,02% | 30.534 SH | 19 Ağustos 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,02% | 25.782 NS | 31 Temmuz 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,02% | 11.168 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,02% | 185.916 SH | 11 Eylül 2026 | Günlük |
| IWB · iShares Trust | 0,02% | 93.225 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,01% | 36.139 SH | 11 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,01% | 5.886 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 3.408 NS | 31 Temmuz 2026 | N-PORT |
| IWD · iShares Trust | 0,01% | 111.121 SH | 11 Eylül 2026 | Günlük |
| REVS · Columbia ETF Trust I | 0,01% | 439 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 4.247.432 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 111.719 SH | 19 Ağustos 2026 | Günlük |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 30.273 SH | 19 Ağustos 2026 | Günlük |
| DFUS · Dimensional ETF Trust | 0,01% | 24.661 NS | 31 Temmuz 2026 | N-PORT |
| IJH · iShares Trust | · | 4.942.845 SH | 11 Eylül 2026 | Günlük |
| IJK · iShares Trust | · | 816.879 SH | 11 Eylül 2026 | Günlük |
| XJH · iShares Trust | · | 19.242 SH | 08 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 5.539 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 10.026 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 45.534 SH | 11 Eylül 2026 | Günlük |
ARWR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 20 analist
AL
Medyan hedef
$104.00
+62,0%
6 30,0%
Güçlü Al
13 65,0%
Al
1 5,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
13 analist · 2026-09-28Ortalama hedef $107.23 +67,1%
← Tüm hedeflerin altında
Mevcut fiyat $64.19
Düşük$74.00
Ortalama$107.23
Yüksek$126.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | · |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | · |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | · |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | · |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | · |
| PCVX | $6.05B | -8.2 | · | · | -26.6% | · |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | · |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 4, 2026